Compile Data Set for Download or QSAR
maximum 50k data
Found 429 of ic50 for UniProtKB: P48736
LigandPNGBDBM169994(US9073940, 344)
Affinity DataIC50:  6nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170092(US9073940, 450)
Affinity DataIC50:  7nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169955(US9073940, 305)
Affinity DataIC50:  11nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170069(US9073940, 427)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170024(US9073940, 376)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170116(US9073940, 474)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170012(US9073940, 364)
Affinity DataIC50:  14nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170114(US9073940, 472)
Affinity DataIC50:  14nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170107(US9073940, 465)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170030(US9073940, 382)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169956(US9073940, 306 | US9073940, 345)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170061(US9073940, 413)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170000(US9073940, 350)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170064(US9073940, 422)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170010(US9073940, 362)
Affinity DataIC50:  17nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170101(US9073940, 459)
Affinity DataIC50:  18nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170105(US9073940, 463)
Affinity DataIC50:  18nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170032(US9073940, 384)
Affinity DataIC50:  19nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170096(US9073940, 454)
Affinity DataIC50:  20nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170088(US9073940, 446)
Affinity DataIC50:  20nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170102(US9073940, 460)
Affinity DataIC50:  21nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170052(US9073940, 404)
Affinity DataIC50:  21nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169952(US9073940, 302)
Affinity DataIC50:  21nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169930(US9073940, 280)
Affinity DataIC50:  22nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170106(US9073940, 464)
Affinity DataIC50:  22nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170037(US9073940, 389)
Affinity DataIC50:  24nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170031(US9073940, 383)
Affinity DataIC50:  24nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170081(US9073940, 439)
Affinity DataIC50:  25nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170067(US9073940, 425)
Affinity DataIC50:  25nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170111(US9073940, 469)
Affinity DataIC50:  25nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170009(US9073940, 361)
Affinity DataIC50:  25nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170011(US9073940, 363)
Affinity DataIC50:  25nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170017(US9073940, 369)
Affinity DataIC50:  27nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170095(US9073940, 453)
Affinity DataIC50:  28nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170093(US9073940, 451)
Affinity DataIC50:  28nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170033(US9073940, 385)
Affinity DataIC50:  29nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169948(US9073940, 298)
Affinity DataIC50:  29nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170034(US9073940, 386)
Affinity DataIC50:  30nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170076(US9073940, 434)
Affinity DataIC50:  31nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170015(US9073940, 367)
Affinity DataIC50:  32nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169956(US9073940, 306 | US9073940, 345)
Affinity DataIC50:  34nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169931(US9073940, 281)
Affinity DataIC50:  34nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170087(US9073940, 445)
Affinity DataIC50:  34nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169933(US9073940, 283)
Affinity DataIC50:  34nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169923(US9073940, 273)
Affinity DataIC50:  36nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170029(US9073940, 381)
Affinity DataIC50:  36nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170062(US9073940, 414)
Affinity DataIC50:  38nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169951(US9073940, 301)
Affinity DataIC50:  38nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170071(US9073940, 429)
Affinity DataIC50:  39nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169996(US9073940, 346)
Affinity DataIC50:  40nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 429 total ) | Next | Last >>
Jump to: